Pancreatic Cancer Screening Program

What is the Purpose of this Study?

The purpose of the study is to establish a pancreatic ductal adenocarcinoma (PDAC) screening program that collects the demographic and clinical information of patients and to study risk factors for progression to pancreatic ductal adenocarcinoma (PDAC) in high-risk patients.


Eligibility

Not Available


Where can I participate?

CS Cancer at Cedars-Sinai Medical Center


What is the full name of this clinical trial?

IIT2020-06-Gaddam-PDAC: Pancreatic Cancer Screening Registry

Study Details
Disease Type/Condition

Pancreas

Principal Investigator

Gaddam, Srinivas

Co-Investigators

Andrew Hendifar, Jun Gong, Michael Luu, Simon Lo, Stephen Pandol

Age Group

Adult

Phase

N/A (Cancer Control) (Cancer Prevention)

IRB Number

STUDY00000248


How do I learn more about this study?
Email
clinicaltrials@cshs.org
Study Detail
Disease Type/Condition

Pancreas

Principal Investigator

Gaddam, Srinivas

Age Group

Adult

Phase

N/A (Cancer Control) (Cancer Prevention)

IRB Number

IIT2020-06-GADDAM-PDAC


Contact
Email
clinicaltrials@cshs.org